Načítá se...
The identification of a novel TP53 cancer susceptibility mutation through whole genome sequencing of a patient with therapy-related AML
CONTEXT: The identification of patients with inherited cancer susceptibility syndromes facilitates early diagnosis, prevention, and treatment. However, in many cases of suspected cancer susceptibility, the family history is unclear and genetic testing of common cancer susceptibility genes is unrevea...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3170052/ https://ncbi.nlm.nih.gov/pubmed/21505135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.473 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|